The Fédération Equestre Internationale (FEI) Tribunal has issued its final decision on the banned substance case involving U.S. show jumper Paige Johnson. Samples taken on Jan. 21 from the horse Luke Skywalker 46, ridden by Johnson, at the CSI2* in Wellington, Florida, tested positive for the local anesthetic pramoxine (a topical pain reliever).
The FEI Tribunal has imposed a one-year suspension. As the athlete was provisionally suspended for three months starting on April 5, Johnson will not be eligible to compete until April 4, 2018. The FEI Tribunal also imposed a fine of 2,000 CHF and contribution of 3,000 CHF towards legal costs.
The athlete has appealed the decision to the court of arbitration for sport. Additional details on the FEI Tribunal Decision are available on the FEI website.
The FEI also reported another adverse analytical finding, this one involving the prohibited substance O-desmethyltramadol, a metabolite of the analgesic tramadol:
Horse: Dalton Des Hayettes
Person Responsible: Pascal Van Laethem (BEL)
Event: CSI2* – Deauville, France, June 15-18
The athlete has been provisionally suspended from the date of notification (Aug. 7) until the FEI Tribunal renders a decision. The horse has been provisionally suspended for two months. Further details can be found on the FEI website.